Becker's Healthcare August 9, 2024
Patsy Newitt

Walgreens could sell off its stake in primary care chain VillageMD — which it acquired in 2021 in a $5.2 billion deal — according to an Aug. 7 Securities and Exchange Commission filing.

Here are five things to know:

1. Walgreens is “currently evaluating a variety of options with respect to VillageMD in light of ongoing investments by the company in VillageMD’s businesses and VillageMD’s substantial ongoing and expected future cash requirement,” the filing said, adding that the options could include sale of “all or part” of VillageMD, as well as possible restructuring options.

2. In the second fiscal quarter of 2024, Walgreens saw a $5.8 billion loss because of an investment devaluation in the primary care clinic...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: ASC, Pharma, Pharma / Biotech, Primary care, Provider
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights
Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin
What might a Trump administration mean for the Biosecure Act?

Share This Article